State policies have had little impact on closing the margin between supply and demand for organ donations, according to a study published this month in JAMA Internal Medicine.
first-person consent laws, donor registries, dedicated revenue streams for donor recruitment activities, population education programs, paid leave for donation, and tax incentives.
State policies have had little impact on closing the margin between supply and demand for organ donations, according to a study published this month in JAMA Internal Medicine. Researchers examined the effects of policies put in place between 1988 and 2010 in all 50 states. They were interested in 6 policies in particular:
With a US average death rate of 21 people per day on transplant lists and average wait times for organ donations ranging anywhere from 4 months to 5 years, the need to close the gap is becoming even more so pressing. In 1988 only 7 states had passed at least 1 donation-related policy, but by 2010 all states had passed at least 1.
The study found that state revenue streams to support recruitment activities such as community outreach, worksite campaigns, and efforts to educate physicians were the only methods that demonstrated meaningful gain, most notably a boost in donated organs by an increase of 15 transplants per year.
Experts suggest that the shortfall in organ donations may be the result of a lack in living organ donations as well as the high cost for the process. Making organ donations financially feasible for donors and families would help close the gap; however, experts suggest that incentives and pure monetary rewards may lead to the exploitation of the poorest population.
New policy designs are needed to increase donation rates and curtail the widening gap between organ supply and demand," the authors concluded.
"
Read more at Kaiser Health News http://bit.ly/1e37jCJ
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen
FIT Completion, Yield Rates in CRC Screening Similar After New Screening Guidelines
October 22nd 2024Patients were found to have similar completion and yield rates for the fecal immunochemical test (FIT) at both 45 years and 50 years, making screening for colorectal cancer (CRC) effective in younger patients.
Read More
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More